bioAffinity Technologies reports 87% jump in lung cancer test revenue

Go back to bioAffinity Technologies reports 87% jump in lung cancer test revenue
(NASDAQ: BIAF) Delayed: 0.39 -0.01 (2.5%)
Previous Close $0.40    52 Week High
Open $0.42    52 Week Low
Day High $0.42    P/E N/A 
Day Low $0.39    EPS
Volume 340,178       

(NASDAQ: BIAFW) Delayed: 0.08 +0.01 (14.29%)
Previous Close $0.07    52 Week High
Open $0.06    52 Week Low
Day High $0.08    P/E N/A 
Day Low $0.06    EPS
Volume 2,629